about
Age-related eye diseases: an emerging challenge for public health professionals"Light" versus "classic" laser treatment for clinically significant diabetic macular oedema.Resource use and costs associated with diabetic macular edema in elderly persons.Knowledge and Use of Low Vision Services Among Persons with Age-related Macular DegenerationPharmacy staff opinions regarding diabetic retinopathy screenings in the community setting: findings from a brief surveyIdentification of noncompliant glaucoma patients using Bayesian networks and the Eye-Drop Satisfaction Questionnaire.Adverse events after pars plana vitrectomy among medicare beneficiaries.Prevalence and determinants of glaucoma in citizens of qatar aged 40 years or older: a community-based surveyEarly Subretinal Allograft Rejection Is Characterized by Innate Immune Activity.Prevalence of major eye diseases among US Civil War veterans, 1890-1910Effects of receipt of guideline-recommended care on onset of diabetic retinopathy and its progression.A Multi-Center Diabetes Eye Screening Study in Community Settings: Study Design and Methodology.Is age-related macular degeneration associated with stroke among elderly americans?Keratoconus in the Medicare population.Retinal photodamage by endogenous and xenobiotic agents.Effect of Visual Impairment on Physical and Cognitive Function in Old Age: Findings of a Population-Based Prospective Cohort Study in Germany.Calpain inhibitor SNJ-1945 attenuates events prior to angiogenesis in cultured human retinal endothelial cells.Antioxidants and the integrity of ocular tissues.Does Visual Impairment Affect Social Ties in Late Life? Findings of a Multicenter Prospective Cohort Study in Germany.Combined impairments in vision, hearing and cognition are associated with greater levels of functional and communication difficulties than cognitive impairment alone: Analysis of interRAI data for home care and long-term care recipients in Ontario.Paths towards efficiency in healthcare.Qualitative assessment of online information about age-related macular degeneration available in Portuguese.Self-reported age-related eye diseases and visual impairment in the United States: results of the 2002 national health interview surveyTrial of a behavioral intervention to increase dilated fundus examinations in African–Americans aged over 65 years with diabetes
P2860
Q25257145-7E05C5A9-C6B0-4A6E-8195-CF281DC38EA8Q33217408-DE7A8963-2B91-4F47-8F0C-579813B85560Q33390920-3EB946B8-CBBD-4C01-A29A-AE20F90F62F5Q33559860-E7B88393-9099-46AB-A987-459BD619E8E7Q33652925-5D06BDC5-5F0B-41C1-A776-24843A341F3FQ34439372-1F6E759A-0C44-4C38-BA15-55FE3FC88949Q34796388-40122105-DD95-4C58-BA50-CCCF2F6BA763Q35057589-45B4CA6A-966D-4339-A346-E01DB7C0C9C1Q36255088-6C6EA9B4-7C1A-47F8-BF31-3862B2237B19Q36622993-A36D6F13-5E98-4AD5-AC5C-352112D886CBQ36740561-0B1D6E05-9AF9-4F6F-895D-D1C130559326Q37024278-07548D81-2BE3-4B0F-99C5-04C00D1FB6E2Q37206264-DA3D7AFF-568A-40F2-AC05-FE2D777B3C7BQ37297303-A5E307D1-0287-41BB-9C66-A44693639059Q38009850-6CB7867C-51FD-4206-BBCD-96B46A77CA1EQ40564236-1C9DDAD7-DFDB-4CA0-B4EB-715CE6477D0FQ41876653-55933B5F-B535-4E30-8478-C755F55A9BD6Q42831147-DF99510D-7332-4368-9674-9E44F6FE719FQ47858501-F9D0B732-7178-486B-BD5B-8632B5CB9358Q49979522-8B6EF4D0-9607-4686-A8E0-C95DB04B02CDQ53111710-38954A6E-2606-4AF7-A22A-EB98310FA379Q55054391-80B2589F-7D5B-4DFA-A887-9963774E8A89Q57099763-B4AD7675-A0CF-4CA0-B23F-97ADA38A6FBCQ58960180-D692A3CB-4D1C-4483-8212-222A2C23195A
P2860
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Longitudinal prevalence of major eye diseases.
@en
Longitudinal prevalence of major eye diseases.
@nl
type
label
Longitudinal prevalence of major eye diseases.
@en
Longitudinal prevalence of major eye diseases.
@nl
prefLabel
Longitudinal prevalence of major eye diseases.
@en
Longitudinal prevalence of major eye diseases.
@nl
P50
P1433
P1476
Longitudinal prevalence of major eye diseases
@en
P2093
Frank A Sloan
Zachary W Feldman
P304
P356
10.1001/ARCHOPHT.121.9.1303
P407
P577
2003-09-01T00:00:00Z